Global Neuro-Oncological Diseases Device Market Size By Type (MRI, CT Scan), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Neuro-Oncological Diseases Device Market was valued at USD 4.3 billion in 2023 and is projected to reach USD 8.1 billion by 2031, growing at a CAGR of 8.1% from 2023 to 2031. The market's growth is propelled by increasing incidences of brain tumors and other neurological cancers, coupled with rapid advancements in diagnostic and therapeutic devices. Heightened awareness of neuro-oncology and rising healthcare expenditures are also contributing to the demand for advanced devices in the diagnosis, treatment, and monitoring of neuro-oncological conditions.

Drivers:

1. Rising Incidence of Neurological Cancers:

The global prevalence of brain and central nervous system cancers is rising, creating urgent demand for more effective diagnostic and therapeutic devices. Increased access to MRI, PET scans, and biopsy-guided systems has accelerated early detection and treatment planning.

2. Technological Advancements in Imaging and Surgical Devices:

Innovation in minimally invasive neurosurgical tools, robotic-assisted surgery, and AI-integrated imaging systems are revolutionizing treatment precision, reducing recovery time, and improving patient outcomes.

3. Expanding Healthcare Infrastructure in Emerging Markets:

Developing countries are significantly increasing investments in specialized oncology units, boosting the availability and affordability of neuro-oncological devices.

Restraints:

1. High Cost of Devices and Procedures:

The high cost associated with neuro-oncological surgeries, imaging technologies, and implantable devices limits access, particularly in low-income regions.

2. Complexity of Treatment and Diagnosis:

The intricate nature of neurological tumors and the delicate structure of the brain pose significant challenges to accurate diagnosis and safe treatment, potentially restricting the market’s expansion.

Opportunity:

1. Integration of AI and Big Data in Neuro-Oncology:

AI-driven diagnostic algorithms and predictive analytics are creating new pathways for personalized treatment and early detection, offering substantial opportunities for innovation.

2. Growth in Telemedicine and Remote Diagnostics:

The growing demand for remote patient management and diagnostic services in neuro-oncology provides a fertile ground for the development of portable and digital health devices.

Market by System Type Insights:

In 2023, the Imaging Devices segment held the dominant share of the market, driven by increased demand for high-precision diagnostic equipment such as MRI, CT, and PET scanners. These tools are vital in tumor localization, grading, and treatment planning. Meanwhile, the Surgical Devices segment is anticipated to witness the fastest growth due to the rising adoption of neuronavigation and stereotactic systems in neurosurgical procedures.

Market by End-use Insights:

Hospitals accounted for the largest share in 2023, supported by extensive infrastructure for advanced neuro-oncological treatment. The Research & Academic Institutes segment is growing rapidly due to increased clinical studies and technological trials for innovative neuro-oncology solutions. Ambulatory surgical centers are also gaining traction for outpatient neuro-diagnostic procedures.

Market by Regional Insights:

North America led the global neuro-oncological diseases device market in 2023, owing to its sophisticated healthcare infrastructure, robust R&D investment, and favorable reimbursement policies. Europe followed closely, supported by increasing brain tumor incidences and public healthcare initiatives. Asia-Pacific is expected to register the highest growth rate, with China, India, and Japan showing strong demand for affordable and efficient neuro-diagnostic and treatment devices.

Competitive Scenario:

Key players in the market include Medtronic plc, GE Healthcare, Siemens Healthineers, Elekta AB, Varian Medical Systems, Accuray Incorporated, Philips Healthcare, Brainlab AG, Monteris Medical, and NeuroLogica Corporation. Companies are focused on product innovation, AI integration, strategic partnerships, and global expansion to gain a competitive edge. Notable developments include:

2023: Siemens Healthineers introduced an AI-powered MRI platform for enhanced neuroimaging accuracy.

2024: Brainlab AG launched a next-generation neuronavigation system with augmented reality (AR) integration.

2025: Medtronic plc acquired a neuro-oncology diagnostics firm to strengthen its product portfolio and market reach.

Scope of Work – Global Neuro-Oncological Diseases Device Market

Report Metric Details

Market Size (2023) USD 4.3 billion

Projected Market Size (2031) USD 8.1 billion

CAGR (2023–2031) 8.1%

Market Segments By System Type (Imaging Devices, Surgical Devices, Monitoring Devices), By End-use (Hospitals, Ambulatory Surgical Centers, Research & Academic Institutes)

Growth Drivers Rising Neurological Cancer Incidence, Technological Advancements, Emerging Healthcare Infrastructure

Opportunities AI Integration, Remote Diagnostics, Emerging Markets Expansion

Key Market Developments:

2023: Siemens Healthineers introduced an AI-powered MRI platform for enhanced brain tumor diagnostics.

2024: Brainlab AG launched a neuronavigation system with AR capabilities for precise tumor resection.

2025: Medtronic acquired a startup specializing in wearable neuro-oncological monitoring devices.

FAQs:

1) What is the current market size of the Global Neuro-Oncological Diseases Device Market?

The market size was USD 4.3 billion in 2023.

2) What is the major growth driver of the Global Neuro-Oncological Diseases Device Market?

The primary driver is the increasing incidence of brain and CNS cancers globally.

3) Which is the largest region during the forecast period in the Global Neuro-Oncological Diseases Device Market?

North America is the leading region due to its advanced healthcare infrastructure and high R&D investment.

4) Which segment accounted for the largest market share in Global Neuro-Oncological Diseases Device Market?

The Imaging Devices segment held the largest market share in 2023.

5) Who are the key market players in the Globa